Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: October 21, 2010
Last updated: October 13, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):